Dottikon ES Holding AG (XSWX:DESN) Research & Development: CHF0.0 Mil (TTM As of Mar. 2026)


XSWX:DESN Dottikon ES Holding AG XSWX:DESN
96 GF Score
Price CHF274.00
GF Value CHF336.76
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dottikon ES Holding AG Research & Development?

Dottikon ES Holding AG XSWX:DESN -0.36% 96 Research & Development is CHF0.0 Mil as of Mar. 2026. GuruFocus rates XSWX:DESN with a GF Score™ of 96/100 and a GF Value™ of CHF336.76 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dottikon ES Holding AG's Research & Development for the six months ended in Mar. 2026 was CHF0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was CHF0.0 Mil.

Dottikon ES Holding AG  (XSWX:DESN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dottikon ES Holding AG Research & Development Related Terms

Dottikon ES Holding AG Research & Development Historical Data

* Premium members only.

The historical data trend for Dottikon ES Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dottikon ES Holding AG Research & Development Chart

Dottikon ES Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dottikon ES Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:DESN
96GF Score
Dottikon ES Holding AG XSWX:DESN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dottikon ES Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0.0 Mil mean?
Dottikon ES Holding AG (XSWX:DESN) has a Research & Development of CHF0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dottikon ES Holding AG and its competitors.
Is Dottikon ES Holding AG's Research & Development too high?
Dottikon ES Holding AG's current Research & Development is CHF0.0 Mil. Overall, Dottikon ES Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dottikon ES Holding AG's Research & Development compare to DOW?
Dottikon ES Holding AG's Research & Development of CHF0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dottikon ES Holding AG and its competitors. Dottikon ES Holding AG's current Research & Development is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dottikon ES Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Dottikon ES Holding AG (XSWX:DESN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF336.76, compared to a current price of CHF274.00 — trading 18.6% below its estimated fair value. The current Research & Development is CHF0.0 Mil. Dottikon ES Holding AG's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dottikon ES Holding AG (XSWX:DESN), the current Research & Development is CHF0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dottikon ES Holding AG (XSWX:DESN) Overvalued in 2026?

Based on GuruFocus' analysis, Dottikon ES Holding AG stock appears to be undervalued. The current stock price of CHF274.00 is trading 18.6% below its estimated GF Value™ of CHF336.76. GuruFocus considers Dottikon ES Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:DESN:

  • Research & Development: CHF0.0 Mil
  • GF Value™: CHF336.76 vs. price of CHF274.00 (18.6% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the XSWX:DESN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dottikon ES Holding AG Business Description

Other Exchanges DESNz:UK0QJU:UKDTI0:Germany
Address Hembrunnstrasse 17, Dottikon, CHE, 5605
Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's chemical, biotech, and pharmaceutical industry.
96GF Score

Get the complete analysis for XSWX:DESN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF274.00
Price
CHF336.76
GF Value